{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:25:09Z","timestamp":1783441509128,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.leukres.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T08:17:22Z","timestamp":1500970642000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"60","author":[{"given":"Vassiliki E.","family":"Mpakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleni-Dikaia","family":"Ioannidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Konsta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrofora","family":"Vikentiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris","family":"Spathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieda","family":"Kontsioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos K.","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios D.","family":"Velentzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiris","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamantina","family":"Vasilatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Gkontopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Glezou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Stavroulaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimia","family":"Mpazani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Kokkori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Karakitsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.07.004_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.critrevonc.2016.06.003","article-title":"Chronic lymphocytic leukaemia","volume":"104","author":"Scarfo","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2012.187","article-title":"Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls","volume":"27","author":"Moreira","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.07.004_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors","volume":"146","author":"Rossi","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2015-03-567388","article-title":"Perturbation of the normal immune system in patients with CLL","volume":"126","author":"Forconi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.004_bib0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(74)90944-1","article-title":"Clinical significance of T-cells in chronic lymphocytic leukaemia","volume":"2","author":"Catovsky","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2017.07.004_bib0030","first-page":"157","article-title":"Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type","volume":"49","author":"Herrmann","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0035","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.129.5.2305","article-title":"Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies","volume":"129","author":"Platsoucas","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0040","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","article-title":"Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine","volume":"106","author":"Beyer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.004_bib0045","doi-asserted-by":"crossref","first-page":"e2012053","DOI":"10.4084\/mjhid.2012.053","article-title":"Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases","volume":"4","author":"D\u2019Arena","year":"2012","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.leukres.2017.07.004_bib0050","first-page":"677","article-title":"Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia","volume":"20","author":"Giannopoulos","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.leukres.2017.07.004_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","article-title":"Immune therapy for cancer","volume":"27","author":"Dougan","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.leukres.2017.07.004_bib0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxw025","article-title":"Roles of regulatory T cells in cancer immunity","volume":"28","author":"Takeuchi","year":"2016","journal-title":"Int. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.smim.2003.12.005","article-title":"Human CD4+CD25+ regulatory T cells","volume":"16","author":"Baecher-Allan","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3109\/10428194.2012.730614","article-title":"Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3","volume":"54","author":"Dasgupta","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2017.07.004_bib0080","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2017.07.004_bib0085","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1002\/eji.200737593","article-title":"Regulatory T cells \u2013 a brief history and perspective","volume":"37","author":"Sakaguchi","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2017.07.004_bib0095","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2017.07.004_bib0100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2017.07.004_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-230X(10)07003-X","article-title":"Regulatory T cells in cancer","volume":"107","author":"Mougiakakos","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.leukres.2017.07.004_bib0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.leukres.2012.10.011","article-title":"Dasatinib inhibits proliferation and induces apoptosis in the KASUMI-1 cell line bearing the t(8;21)(q22;q22) and the N822K c-kit mutation","volume":"37","author":"Mpakou","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.07.004_bib0120","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/10428190902803677","article-title":"Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia","volume":"50","author":"Jak","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2017.07.004_bib0125","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cncr.25752","article-title":"Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia","volume":"117","author":"Weiss","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2017.07.004_bib0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/modpathol.2011.164","article-title":"Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia","volume":"25","author":"Biancotto","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0135","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3109\/10428194.2012.728287","article-title":"Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias","volume":"54","author":"Lad","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2017.07.004_bib0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2011.04466.x","article-title":"Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells","volume":"166","author":"Piper","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0145","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood.V91.11.4273","article-title":"Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1\/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia","volume":"91","author":"Tinhofer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.004_bib0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/eji.200939261","article-title":"CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets","volume":"39","author":"Rudd","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0105-2896.2006.00419.x","article-title":"The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology","volume":"212","author":"Sansom","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.leukres.2017.07.004_bib0160","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ajh.23170","article-title":"A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia","volume":"87","author":"D\u2019Arena","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2567.2011.03439.x","article-title":"Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro","volume":"133","author":"Lindqvist","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2017.07.004_bib0170","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","article-title":"Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.004_bib0175","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.004_bib0180","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.seminhematol.2014.05.006","article-title":"Immunomodulation and immune reconstitution in chronic lymphocytic leukemia","volume":"51","author":"Riches","year":"2014","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.leukres.2017.07.004_bib0185","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2017.07.004_bib0190","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8T cells","volume":"115","author":"Gorgun","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2017.07.004_bib0195","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:51:42Z","timestamp":1692899502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617304691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":39,"alternative-id":["S0145212617304691"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.07.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}